Evaluation of smart microcarriers for high-density culture and enzymefree harvesting of primary dermal sheath cells and fibroblasts

RepliCel is a regenerative medicine company that develops autologous cell therapies to treat chronic tendinosis, UV-damaged or aged skin, and pattern baldness. The cells in this technology are isolated from skin biopsies obtained from patients. However, because of limited available tissue samples, RepliCel seeks novel technologies to improve their cell culture process, which is currently […]

Read More